12 December 2024
	

Benchmark Holdings plc 
("Benchmark", the "Company" or the "Group")
Q4 Results 
(3 months ended 30 September 2024)

Resilient performance in a period of trading headwinds and change
Business areas well positioned for future development

In compliance with the terms of the Company's unsecured green bond which
requires it to publish quarterly financial information, Benchmark, the
aquaculture biotechnology business, announces its unaudited results for the 3
months ended 30 September 2024 (the "period"). All Q4 FY24 and Q4 FY23 figures
quoted in this announcement are based on unaudited accounts. 

This morning the Company published its full year audited results for the 12
months ended 30 September 2024 which can be found on
https://www.benchmarkplc.com/investors

The Genetics business which is the subject of a post period end disposal has
been treated as held for sale and discontinued in this statement and in the
Annual Report. The 2024 results for Genetics have been included in the narrative
below to enable our shareholders to evaluate the performance and development of
the group as a whole before this disposal took place

Q4 FY24 Financial highlights  
o	Total Revenues (continuing and discontinued) operations of £36.8m, 1% ahead of
the prior year (+7% at constant exchange rate (CER)):
o	Advanced Nutrition - strong performance against a backdrop of challenging
conditions in the global shrimp markets